Current global status & impact of human papillomavirus vaccination: Implications for India - Test2 - elhamkhani - TriplyDB

Current global status & impact of human papillomavirus vaccination: Implications for India

Current global status & impact of human papillomavirus vaccination: Implications for India

http://www.wikidata.org/entity/Q28079776

about

Management algorithms for cervical cancer screening and precancer treatment for resource-limited settings.Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017.

P2860

Q40129828-65CC46B4-9E35-44C0-A282-E926178BAC6F Q50034272-063BDA0D-3C79-4D25-97F8-54A63BC8076C

P2860

Current global status & impact of human papillomavirus vaccination: Implications for India

http://www.wikidata.org/entity/Q28079776

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Current global status & impact ...... nation: Implications for India

@ast

Current global status & impact ...... nation: Implications for India

@en

Current global status & impact ...... nation: Implications for India

@nl

type

label

Current global status & impact ...... nation: Implications for India

@ast

Current global status & impact ...... nation: Implications for India

@en

Current global status & impact ...... nation: Implications for India

@nl

prefLabel

Current global status & impact ...... nation: Implications for India

@ast

Current global status & impact ...... nation: Implications for India

@en

Current global status & impact ...... nation: Implications for India

@nl

P1433

Q28079776-C103EB80-9163-4CD4-BFFC-4B4C4F215ED0

P1476

Q28079776-DB6E2334-0BC3-49E1-A803-9E51A7F2BA1A

P2093

Q28079776-70030023-CBAD-449B-AA21-0AA99B1A6E33

Q28079776-86CE2F25-837B-4677-9A07-3DD799997AD3

P275

Q28079776-1722C7CB-0F9C-4746-8C90-EFC64345D296

P2860

Q28079776-0FD8AB85-0A04-4499-847E-83010FBB0A98

Q28079776-1096A722-899C-4EFF-A5F0-A94E9A2084F7

Q28079776-125FDF03-343F-416A-B67C-AC65F7984A15

Q28079776-18356906-9B30-4B9D-B137-F0AF17AE6AD0

Q28079776-1C716AF5-C288-4820-A2F4-919F6BBE8016

Q28079776-1DB0E3F5-D98C-46A9-8A32-60B848C54E61

Q28079776-2257F3C6-8512-488A-A9E8-6CAD012040D1

Q28079776-23BED2E3-3697-4763-8988-D72F2E9C0F06

Q28079776-24660835-2FEF-4FDC-B5B5-F0117ADA2AF6

Q28079776-27231D79-A1E8-41A3-8EC5-13887636F102

P304

Q28079776-AF42C80D-F6DB-466C-BDE3-62967680FC1F

P31

Q28079776-18C79617-9B45-4CC2-AB26-1E4D96B1C74E

Q28079776-A2BE5604-8DF4-4D5C-B8B2-5A0C5C34985C

P3181

Q28079776-44308A47-BCF3-47B6-8026-2075E159356A

P356

Q28079776-CAF09440-24C9-48D7-9D19-D14F168D62ED

P407

Q28079776-6BBBBF8A-753A-4F73-ADFA-972D75B136F9

P433

Q28079776-5D016DDA-F2CA-4814-970F-018C627574CD

P478

Q28079776-0A395C79-A9EC-4802-B770-BB44E05A6179

P50

Q28079776-D5DE6B9F-16EC-4258-AC3B-0B2EA5F86A36

P5008

Q28079776-5F4B502B-9637-4713-BBA7-C4DFECCE86DF

P577

Q28079776-2006E792-5961-42B3-9709-62A68AF52321

Q28079776-A2907C81-42F1-4AD3-823B-FAFDA35D33B3

P698

Q28079776-3D5FC6C2-62D5-42D7-8066-F76918031E06

P921

Q28079776-17F7CCC3-4F26-4C3F-B570-60CDA851B50E

Q28079776-2E1F25C0-4236-4B63-9DA1-83866387A472

Q28079776-702A05D6-2F85-4846-84EC-AB348E721F2F

Q28079776-7ECAB829-4FCC-4151-8216-A9A77713AE87

Q28079776-80406C65-1CEC-4422-9A76-E15D328126DE

Q28079776-BC7960EE-2CA2-4477-94B3-DF6FBF692EC1

P932

Q28079776-D063114B-F67E-45E5-A27B-107A42ED531C

P3181

P356

0971-5916.195023

P1433

Indian Journal of Medical Research

P1476

Current global status & im ...... nation: Implications for India

@en

P2093

Partha Basu

http://www.w3.org/2001/XMLSchema#string

Rengaswamy Sankaranarayanan

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

P2860

Achieving high coverage in Rwanda's national human papillomavirus vaccination programme

Gavi HPV Programs: Application to Implementation

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Epidemiologic classification of human papillomavirus types associated with cervical cancer

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

P304

169-180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4356940

http://www.w3.org/2001/XMLSchema#string

P356

10.4103/0971-5916.195023

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

144

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27934795

http://www.w3.org/2001/XMLSchema#string

P921

pre-malignant neoplasm

cervical cancer

uterine cervix neoplasm

tumor virus infections

P932

5206867

http://www.w3.org/2001/XMLSchema#string